Epidemiological and clinical-pathologic characterization of patients with cancer in the anal region

Authors

Keywords:

ANUS NEOPLASMS, RISK FACTORS, HUMAN PAPILLOMAVIRUS, PAPILLOMAVIRUS INFECTIONS, PATIENTS.

Abstract

Introduction: cancer in the anal region is a rare disease into the colorectal and gastrointestinal tract malignancies.  Epidermoid carcinoma is the most common type of malignancies found in all lesions at this level. Among the risk factors for the infection of human papilloma virus [HPV], it constitutes one of the most important related to the onset of this cancer.

Objective: to characterize epidemiological, clinical and pathologic aspects of patients with cancer in the anal region at Dr. Salvador Allende clinical-surgical-teaching hospital in the period 2017-2019.

Methods: an observational, descriptive, longitudinal-prospective study was conducted in patients with the diagnosis of cancer in the anal region during 2017-2019 attending Dr. Salvador Allende clinical-surgical-teaching hospital, La Habana. The target group comprised all patients with cancer in the anal region, who were scheduled to the coloproctology consulting room, and the sample included 17 patients who met the inclusion criteria. The sources of information were: individual clinical history, reports of the biopsy from the pathology department and microbiology laboratory.

Results: women older than 66 years old, with a past history of anal lesions and infection of human papilloma virus [HPV] as risk factors, and presenting as the most frequent clinical manifestations a hemorrhage and a palpable tumor predominated. Well-differentiated tumors with localization in the anal conduct having more than 6 months from the beginning of the symptoms were the most frequent. Neoadjuvant chemotherapy (NACT) was the treatment applied.

Conclusions: the characterization of patients with cancer in the anal region allowed knowing the behavior and characteristics of this disease among the population.

Downloads

Download data is not yet available.

Author Biography

Ivan Bustinzuriaga Marto, Universidad de Ciencias Mèdicas de Pinar del Rìo

Especialista de Primer Grado en Medicina General Integral. Profesor Asistente

References

1. Beltrán Molina, E.; Vázquez Pérez, D.; Peña Mantilla A. El cáncer, una epidemia silenciosa. Rev. Infociencia [Internet]. 2019 [citado 12/12/2020]; 18(1): 1-11. Disponible en: http://www.infocienciass.cu/index.php/infociencia/article/ view/281/458.

2. Aguiar C, Jaumandreu S, Álvarez C, Rodríguez MC. Uso de la cromoendoscopía digestiva con magnificación en el diagnóstico de la neoplasia intraepitelial anal. Acta Gastroenterol Latinoam. [Internet] 2018 [citado 12/12/2020]; 48(3): 206-12. Disponible en: https://actagastro.org/uso-de-la-cromoendoscopia-digestiva-con-magnificacion-en-el-diagnostico-de-la-neoplasia-intraepitelial-anal/

3. González Valdés M. Anuario Estadístico de Salud de Cuba. revmedicaelectronica [Internet]. 2016 [citado 2019]; 38(5): 60-65 Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/1720/317

4. Palefsky J. Human papillomavirus infection and its role in the pathogenesis of anal cancer. Seminars in Colon and Rectal Surgery. [Internet] 2017 [citado 12/12/2020]; 28(2): 57-62. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1043148917300118

5. Muñoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clinical Virol. [Internet] 2016 [citado 12/12/2020]; 19(1-2): 1-5. Disponible en: http://doi.org/10.1016/S1386-6532(00)00125-6

6. Valvo F. Reviews in Oncology. [Internet] 2019 [citado en 2019]; 135: 115–27. Disponible en: www.elsevier.com/locate/critrevonc.

7. Serra Fernando O, Chacón C. Avances en el diagnóstico precoz y tratamiento del cáncer de ano. Rev. ArgColoproct [Internet]. 2017 [citado 12/12/2020]; 23: 121-74. Disponible en: www.sacp.org.ar

8. Colón-López V, Shiels MS, Machin M. Anal cancer risk among people with HIV infection in the United States. Journal of Clinical Oncology 2018 [citado 12/12/2020]; 36(1): 68. Disponible en: http://www.ncbi.nlm.nih. gov.

9. Rodríguez Wong U, Medina Murillo R. Virus del papiloma humano y carcinoma epidermoide anal. Rev. Hosp Jua Mex [internet] 2017 [citado 12/12/2020]; 73(2). Disponible en: http://www.infomed.com.mx/1/1/articulos.

10. González Martínez G, Núñez J. Tratamiento de las verrugas genitales: una actualización. Rev. Chil Obstet Ginecol. [Internet]. 2015 [citado 12/12/2020]; 80 (1): 76-83. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262015000100012&lng=es

11. Llorente LFF, Rengifo GC. Prevalencia de infección anal por el virus del papiloma humano en el Hospital "Comandante Manuel Fajardo". RevCub Cir. [Internet] 2017 [citado 12/12/2020]; 56(1). Disponible en: https://www.medigraphic.com/pdfs/cubcir/rcc-2017/rcc171d.pdf

12. Pérez Pérez N, Suzuki V, Tinnirello MA, Cora Eliseht M, Blanco A. Tamizaje en mujeres para el cáncer de canal anal HPV relacionado. Rev. Colposcopia, Argent. [Internet] 2018 [citado 12/12/2020]; 29(1): 59-67. Disponible en: www.ginecotocologicab.hc.edu.uy

13. Ferrer Márquez M, Velasco Albendeab F, Lozanoa R, Berenguel M. Adenocarcinoma del canal anal. Revisión de conjunto. [Internet] 2013 [citado 12/12/2020]; 91(5): 281-86. Disponible en: http://dx.doi.org/10.1016/j.ciresp.2013.01.002

14. Lamas Ainzuín C, Payet Garreta C. Cáncer de Ano. Universidad Nacional de San Marcos. Perú. [Internet] 2016 [citado 12/12/2020]; 50(2). Disponible en: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/5301

15. Paredes Torres JM. Evaluación de respuesta y supervivencia en cáncer anal postquimioterapia y radioterapia concurrente Hospital Nacional Cayetano Heredia 2010-2016 Lima. Perú. [Internet] 2018 [citado 12/12/2020]; Disponible en: www.repositorioacademico.usmp.edu.pe/handle/usmp/4384

Downloads

Published

2021-09-20

How to Cite

1.
Zubizarreta Sotolongo JA, Bustinzuriaga Marto I, Dimas Rosabal H, Fernández Pérez F. Epidemiological and clinical-pathologic characterization of patients with cancer in the anal region. Rev Ciencias Médicas [Internet]. 2021 Sep. 20 [cited 2025 Sep. 12];25(5):e5203. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5203

Issue

Vol. 25 No. 5 (2021)

Section

BRIEF COMMUNICATION

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/